Cumberland Pharmaceuticals(us:CPIX)

4.36

+3.07%

Updated on 2025-04-02

Open:4.23
Close:4.36
High:4.41
Low:4.18
Prev Close:4.23
Volume:33426.00
Turnover:144301.91
Turnover Ratio:0.24%
Shares:13.97M
MarketCap:60.90M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3025207750414.75%248
2024-03-3126216291615.27%1512
2023-12-3125219788815.56%457
2023-09-3025220794015.53%2212
2023-06-3024239941016.74%348
2023-03-3124244730516.96%1412
2022-12-3123249310417.35%646
2022-09-3022244644616.95%0211
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Renaissance Technologies Llc5426633.83%-7200-1.31%
2024-03-31Vanguard Group Inc3742512.64%0
2024-03-31Dimensional Fund Advisors Lp3576152.53%-8319-2.27%
2024-03-31Bridgeway Capital Management, Llc2866552.02%0
2024-03-31Acadian Asset Management Llc1881641.33%0
2024-03-31Blackrock Inc.1105640.78%-426-0.38%
2024-03-31Geode Capital Management, Llc845220.60%-752-0.88%
2024-03-31Bank Of New York Mellon Corp752680.53%0
2024-03-31State Street Corp337000.24%-6090-15.30%
2024-03-31Two Sigma Investments, Lp324300.23%-600-1.82%

About

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.
Address:1600 West End Avenue,Suite 1300

Market Movers